- What do patients want from the National Health Insurance?
-
Won SS, Shin HY
- KMID: 2252027
- Korean J Hematol.
- 2010 Dec;45(4):217-218.
- doi: 10.5045/kjh.2010.45.4.217
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
-
Kim HK
- KMID: 2252026
- Korean J Hematol.
- 2010 Dec;45(4):215-216.
- doi: 10.5045/kjh.2010.45.4.215
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Mesenchymal stromal cells: new insight on their identity and potential role in cell therapy
-
Oh IH
- KMID: 2252029
- Korean J Hematol.
- 2010 Dec;45(4):219-221.
- doi: 10.5045/kjh.2010.45.4.219
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concerns in assessing risk factors for herpes zoster infection in multiple myeloma patients
-
Lee DG
- KMID: 2252044
- Korean J Hematol.
- 2010 Dec;45(4):286-286.
- doi: 10.5045/kjh.2010.45.4.286
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Auer rod-like crystal inclusions in plasma cells of multiple myeloma
-
Oh SH, Park CJ
- KMID: 2252030
- Korean J Hematol.
- 2010 Dec;45(4):222-222.
- doi: 10.5045/kjh.2010.45.4.222
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma
-
Choi Q, Kim HK
- KMID: 2252031
- Korean J Hematol.
- 2010 Dec;45(4):223-223.
- doi: 10.5045/kjh.2010.45.4.223
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant
-
Park H, Lee MJ, Kim Y, Min YH, Kim SJ, Kim D
- KMID: 2252041
- Korean J Hematol.
- 2010 Dec;45(4):275-278.
- doi: 10.5045/kjh.2010.45.4.275
Invasive aspergillosis (IA) is a leading cause of infectious mortality in patients who have undergone a hematopoietic stem cell transplant (HSCT); the mortality due to IA ranges from 70% to... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of the complement inhibitor eculizumab (Soliris(R)) for treating Korean patients with paroxysmal nocturnal hemoglobinuria
-
Kim JS, Lee JW, Kim BK, Lee JH, Chung J
- KMID: 2252040
- Korean J Hematol.
- 2010 Dec;45(4):269-274.
- doi: 10.5045/kjh.2010.45.4.269
BACKGROUND: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder characterized by chronic complement-mediated hemolysis. Eculizumab, a humanized monoclonal antibody against the terminal complement protein C5, potently reduces chronic intravascular... -
- CITED
-
- Close
- SHARE
-
- Close
- The immunobiology of cord blood transplantation
-
Szabolcs P
- KMID: 2252032
- Korean J Hematol.
- 2010 Dec;45(4):224-235.
- doi: 10.5045/kjh.2010.45.4.224
Despite significant recent advances in the applicability and outcome following unrelated cord blood transplantation (UCBT), infections remain a major cause of mortality associated with poor immune recovery in the first... -
- CITED
-
- Close
- SHARE
-
- Close
- Wernicke's encephalopathy following allogeneic hematopoietic stem cell transplantation
-
Choi YJ, Park SJ, Kim JS, Kang EJ, Choi CW, Kim BS
- KMID: 2252042
- Korean J Hematol.
- 2010 Dec;45(4):279-281.
- doi: 10.5045/kjh.2010.45.4.279
Wernicke's encephalopathy is caused by thiamine deficiency, and is characterized by acute mental confusion, ataxia, and ophthalmoplegia. It is also a rare neurologic complication of hematopoietic stem cell transplantation (HSCT).... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of p16 in the pathogenesis of Langerhans cell histiocytosis
-
Kim SY, Kim HJ, Kim HJ, Park MR, Koh KN, Im HJ, Lee CH, Seo JJ
- KMID: 2252035
- Korean J Hematol.
- 2010 Dec;45(4):247-252.
- doi: 10.5045/kjh.2010.45.4.247
BACKGROUND: It has been hypothesized that genetic alteration at the cellular level may have a significant effect on cellular mechanisms controlling the proliferation and apoptosis of Langerhans cells (LCs). METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy
-
Shin DY, Lee YG, Lee HJ, Choi S, Park JJ, Kim DW
- KMID: 2252043
- Korean J Hematol.
- 2010 Dec;45(4):282-285.
- doi: 10.5045/kjh.2010.45.4.282
Primary cardiac lymphoma (PCL) is a rare disease entity with only a few reported cases in Korea. In this paper, we report a case of PCL in a 59-year-old man... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis
-
Park R, Song J, An SS
- KMID: 2252039
- Korean J Hematol.
- 2010 Dec;45(4):264-268.
- doi: 10.5045/kjh.2010.45.4.264
BACKGROUND: In sepsis, large scale inflammatory responses can cause extensive collateral damage to the vasculature, because both coagulation and fibrinolysis are activated unevenly. Thrombin-activatable fibrinolysis inhibitor (TAFI) plays a role... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis of non-overt disseminated intravascular coagulation made according to the International Society on Thrombosis and Hemostasis criteria with some modifications
-
Lee JH, Song J
- KMID: 2252037
- Korean J Hematol.
- 2010 Dec;45(4):260-263.
- doi: 10.5045/kjh.2010.45.4.260
BACKGROUND: An early diagnosis of disseminated intravascular coagulation (DIC) before its progression to an overt stage is necessary for early treatment and positive outcomes. In 2001, the Scientific and Standardization... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults
-
Lee JH, Kwon KA, Lee S, Oh SY, Kim SH, Kwon HC, Han JY, Song MK, Chung JS, Lee HS, Kim YS, Lee SM, Joo YD, Kim HJ
- KMID: 2252034
- Korean J Hematol.
- 2010 Dec;45(4):242-246.
- doi: 10.5045/kjh.2010.45.4.242
BACKGROUND: Cytogenetic abnormalities (CAs) have been reported frequently in patients with otherwise typical aplastic anemia (AA), but their implications in the prognosis and in the evolution to hematologic malignancies are... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol
-
Kim MH, Choi CS, Lee JW, Jang PS, Chung NG, Cho B, Jeong DC, Kim HK
- KMID: 2252033
- Korean J Hematol.
- 2010 Dec;45(4):236-241.
- doi: 10.5045/kjh.2010.45.4.236
BACKGROUND: Combination treatment with all-trans-retinoic acid (ATRA) and anthracycline-based chemotherapy has led to major advances in the treatment of acute promyelocytic leukemia (APL). METHODS: In this study, we reviewed the outcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
-
Hong J, Kim AJ, Park JS, Lee SH, Lee KC, Park J, Sym SJ, Cho EK, Shin DB, Lee JH
- KMID: 2252036
- Korean J Hematol.
- 2010 Dec;45(4):253-259.
- doi: 10.5045/kjh.2010.45.4.253
BACKGROUND: Standard treatment for stage I or non-bulky stage II diffuse large B-cell lymphoma (DLBCL) has been either a brief course of chemotherapy plus involved-field radiotherapy (IFRT) or prolonged cycles... -
- CITED
-
- Close
- SHARE
-
- Close
